Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 830 of 1,261
  1. US 8653286

    Intermediates useful in the preparation of maleimide functionalized polymers

    Nektar Therapeutics · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  2. US 8653070

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  3. US 8653027

    Method of treatment of type-1 diabetes with humanin analogues

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  4. US 8653243

    Pertussis antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  5. US 8653283

    Anticancer agents

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  6. US 8653107

    Fentanyl composition for nasal administration

    Takeda Pharma A/S · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  7. US 8652776

    Prediction of QT prolongation based on SNP genotype

    VANDA PHARMACEUTICALS INC. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  8. PH 12013502690

    ANTIBODIES TO ADP-RIBOSYL CYCLASE 2

    BERLIN CHEMIE AG [DE] · Granted Feb 17, 2014 · Expires Feb 12, 2034

    granted
  9. US 8648059

    Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  10. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  11. US 8647646

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  12. US 8648105

    Diarylthiohydantoin compounds

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  13. US 8646246

    Method of preparing a composition in blister packages

    Quantum Hi-Tech (Beijing) Research Institute · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  14. US 8647637

    Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs

    The Board of Regents for Oklahoma State University · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  15. US 8647633

    Recombinant F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  16. US 8646461

    Device and method for simulating chemosensation of smoking

    Sentiens, LLC · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  17. US 8647842

    Methods for producing a fusion protein capable of binding VEGF

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  18. US 8647818

    Molecular scaffolds for HIV-1 immunogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  19. US 8647670

    Biocompatible rapid-gelating hydrogel and associated preparation method of spray

    BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  20. US 8647837

    Artificial tissue constructs comprising alveolar cells and methods for using the same

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  21. US 8648079

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  22. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    TAKEDA GMBH · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  23. US 8648067

    Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligands

    Teva Sante · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted
  24. US 8648102

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.